Although anti-inflammatory drugs have shown promising results in preclinical cardiovascular research, they have yielded little benefit in clinical trials. Before we can expect positive outcomes, we need to find ways of stratifying patients based on their infectious, inflammatory and autoimmune profile, and identify the right time of treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Everett, B. M. et al. Am. Heart J. 166, 199–207.e15 (2013).
Ridker, P. M. et al. N. Engl. J. Med. 377, 1119–1131 (2017).
Tardif, J.-C. et al. N. Engl. J. Med. 381, 2497–2505 (2019).
Abbate, A. et al. Am. J. Cardiol. 111, 1394–1400 (2013).
Schulz, T. F. Int. J. Cancer 125, 1755–1763 (2009).
Ridker, P. M. et al. Lancet 390, 1833–1842 (2017).
Kreiner, E. et al. J. Allergy Clin. Immunol. 140, 771–781 (2017).
Piché, M.-E., Tchernof, A. & Després, J.-P. Circ. Res. 126, 1477–1500 (2020).
Ridker, P. M. Lancet 391, 319–328 (2018).
Abplanalp, W. et al. Eur. Heart J. 44, (2023).
Rieckmann, M. et al. J. Clin. Invest. 129, 4922–4936 (2019).
Sattler, S. ESC Hear. Fail. https://doi.org/10.1002/ehf2.14636 (2023).
Mallat, Z. & Binder, C. J. Nat. Cardiovasc. Res. 1, 431–444 (2022).
Sicklinger, F. et al. Circ. Res. 127, 1214–1216 (2020).
Forte, E. et al. J. Cell. Mol. Med. 25, 229–243 (2021).
Acknowledgements
The thoughts presented in this Comment have been refined through many conversations with like-minded fellow cardioimmunologists. In particular, I would like to acknowledge G. Campos Ramos, M. Kallikourdis and P. Alcaide. This work was supported by funding from the Austrian Science Fund (P36588-B), the British Heart Foundation (P84083), and the Leducq Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sattler, S. Finding the right balance on the challenging path to clinical translation of anti-inflammatory therapies for ischemic heart disease. Nat Cardiovasc Res 3, 245–247 (2024). https://doi.org/10.1038/s44161-024-00440-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44161-024-00440-0